CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma

Figure 8

Promoter methylation levels of CYP2J2 in KIRC were evaluated by box plot using the UALCAN database. (a–d) Box plots showing the association of sample types, patient’s race, age, and nodal metastasis status with promoter methylation level of CYP2J2 in KIRC.

(a)

(b)

(c)

(d)